Notice: This company has been marked as potentially delisted and may not be actively trading. NYSE:CRY CryoLife (CRY) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock Analysis About CryoLife Stock (NYSE:CRY) 30 days 90 days 365 days Advanced Chart Ad DTIWhy I'm telling friends to avoid gold stocksBack in November, gold made a tiny move of 1.6%. But according to my backtesting by using a special type of gold trade, I would have seen a 141% gain in just a week. It happened again in March. Gold nudged up 1.2%. This time? A 104% overnight gain. And in June? A 1% gold move turned into a 74% gain in two weeks. Granted, there would have been smaller wins and those that did not work out, but you see, there's a reason I'm telling all my friends to hold off from buying gold or regular gold stocks right now. There's a more lucrative way to play the gold market as we enter a new breakout period. It's all about catching what I call "Acceleration Cycles."And if you’d like to get your hands on this, here you go, the complete breakdown. Get CryoLife alerts:Sign Up Key Stats Today's Range N/A50-Day Range$17.19▼$21.7252-Week Range N/AVolume7,792 shsAverage Volume198,221 shsMarket Capitalization$703.22 millionP/E Ratio596.20Dividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewCryoLife, Inc. engages in the manufacture, process and distribution of medical devices and implantable human tissues. It operates through the Medical Devices and Preservation Services segments. The Medical Devices segment includes revenues from sales of BioGlue products, aortic stents and stent grafts, On-X products, CardioGenesis cardiac laser therapy, PerClot, and PhotoFix. The Preservation Services segment focuses on revenues from preservation of cardiac and vascular implantable human tissues. The company was founded on January 19, 1984 and is headquartered in Kennesaw, GA.Read More… Receive CRY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for CryoLife and its competitors with MarketBeat's FREE daily newsletter. Email Address CRY Stock News HeadlinesUS medical device giant Artivion says hackers stole files during cybersecurity incidentDecember 10, 2024 | finance.yahoo.comJudith Jamison, acclaimed Alvin Ailey American dancer and director, dead at 81November 11, 2024 | usatoday.comCrypto’s hidden gem + greatest crypto bull run in history = $$$?You don’t actually want to buy Bitcoin this time around. That’s because there’s a better way to take advantage of this new bull market… One market expert calls it Crypto’s Hidden Gem And it’s a new way that has given folks like you and me the chance to see bigger and faster moves than the traditional way of buying Bitcoin… That means if you’ve stayed away from Bitcoin and crypto because it's confusing or seems risky… This is a much safer and better approach to ride this years’ crypto bull run. Because believe it or not… The 2024 crypto bull run is one you DON’T want to miss.December 21, 2024 | ProsperityPub (Ad)Artivion price target raised to $35 from $32 at Lake StreetNovember 10, 2024 | markets.businessinsider.comJudith Jamison, Alvin Ailey Dancer of ‘Power and Radiance,’ Dies at 81November 10, 2024 | nytimes.comArtivion (AORT) Receives a Buy from Lake StreetNovember 5, 2024 | markets.businessinsider.comBiosurgery Market Projected to Surge, Driven by Aging Populations and Demand for Minimally Invasive SolutionsOctober 29, 2024 | finance.yahoo.comArtivion: Undervalued Leader in Cardiovascular Innovations with Promising Growth PotentialOctober 23, 2024 | markets.businessinsider.comSee More Headlines CRY Stock Analysis - Frequently Asked Questions How were CryoLife's earnings last quarter? CryoLife, Inc. (NYSE:CRY) released its quarterly earnings results on Thursday, November, 4th. The medical equipment provider reported $0.26 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.04 by $0.22. The medical equipment provider had revenue of $72.21 million for the quarter, compared to the consensus estimate of $72.90 million. CryoLife had a trailing twelve-month return on equity of 4.24% and a net margin of 0.63%. Does CryoLife have any subsidiaries? CryoLife subsidiaries include these companies: JOTEC AG, On-X Life Technologies Inc., Hemosphere, Cardiogenesis Corporation, AuraZyme Pharmaceuticals Inc., CryoLife Asia Pacific PTE. Ltd., CryoLife Canada Inc., and more. What other stocks do shareholders of CryoLife own? Based on aggregate information from My MarketBeat watchlists, some other companies that CryoLife investors own include Energy Transfer (ET), Johnson & Johnson (JNJ), AT&T (T), Meta Platforms (META), Gilead Sciences (GILD), International Business Machines (IBM) and Netflix (NFLX). Company Calendar Last Earnings11/04/2021Today12/21/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Surgical & Medical Instruments Sub-IndustryHealth Care Equipment Current SymbolNYSE:CRY CUSIP22890310 CIK784199 Webwww.cryolife.com Phone(770) 419-3355Fax770-426-0031Employees1,200Year Founded1984Profitability EPS (Most Recent Fiscal Year)$0.03 Trailing P/E Ratio596.20 Forward P/E RatioN/A P/E GrowthN/ANet Income$-16,680,000.00 Net Margins0.63% Pretax Margin0.41% Return on Equity4.24% Return on Assets1.63% Debt Debt-to-Equity Ratio0.99 Current Ratio4.21 Quick Ratio2.93 Sales & Book Value Annual Sales$253.23 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow23.30 Book Value$8.46 per share Price / BookN/AMiscellaneous Outstanding Shares39,330,000Free Float37,560,000Market Cap$703.22 million OptionableOptionable Beta1.53 Social Links 5G Stocks: The Path Forward is ProfitableClick the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report This page (NYSE:CRY) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTop Picks for Trump’s Pro-Crypto AmericaCoins Set to Soar with a Pro-Crypto White House President-Elect Donald Trump is reported to be holding over...Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CryoLife, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CryoLife With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.